MedPath

University Hospital Heidelberg

University Hospital Heidelberg logo
🇩🇪Germany
Ownership
Private
Established
1388-01-01
Employees
-
Market Cap
-
Website
https://www.klinikum.uni-heidelberg.de/Startseite.2.0.html?&no_cache=1

Gastric Venous Reconstruction After Total Pancreatectomy

Not Applicable
Not yet recruiting
Conditions
Pancreas Cancer
Pancreatectomy
Interventions
Procedure: Gastric venous reconstruction
First Posted Date
2021-04-20
Last Posted Date
2023-12-13
Lead Sponsor
University Hospital Heidelberg
Target Recruit Count
20
Registration Number
NCT04850430
Locations
🇩🇪

Surgery clinic, Heidelberg, Germany

🇩🇪

Professor Dr. med. Arianeb Mehrabi, Heidelberg, Germany

Stereotactic MRI-guided Radiation Therapy for Localized ProstatE Cancer

Not Applicable
Active, not recruiting
Conditions
Prostate Cancer
Interventions
Radiation: MR-guided Radiotherapy
First Posted Date
2021-04-15
Last Posted Date
2025-02-20
Lead Sponsor
University Hospital Heidelberg
Target Recruit Count
68
Registration Number
NCT04845503
Locations
🇩🇪

University Hospital of Heidelberg, Radiation Oncology, Heidelberg, Germany

Glioblastoma Radiotherapy Using IMRT or Proton Beams

Not Applicable
Recruiting
Conditions
Glioblastoma
Interventions
Radiation: Photon irradiation
Radiation: Proton irradiation
First Posted Date
2021-02-12
Last Posted Date
2024-01-05
Lead Sponsor
University Hospital Heidelberg
Target Recruit Count
326
Registration Number
NCT04752280
Locations
🇩🇪

Universitätsklinikum Gießen und Marburg, Marburg, Germany

🇩🇪

Klinikum Stuttgart, Stuttgart, Germany

🇩🇪

Universitätsklinikum Heidelberg, Heidelberg, Germany

Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial

Phase 1
Completed
Conditions
Colorectal Cancer Metastatic
Pancreatic Cancer Metastatic
Interventions
Combination Product: Nivolumab plus Ipilimumab plus Maraviroc
First Posted Date
2021-01-22
Last Posted Date
2023-10-17
Lead Sponsor
University Hospital Heidelberg
Target Recruit Count
50
Registration Number
NCT04721301
Locations
🇩🇪

University of Heidelberg / NCT, Heidelberg, Germany

Daunorubicin or Idarubicin With Cytarabine Plus Quizartinib vs Physician's Choice in Newly Diagnosed FLT3-ITD+ AML

Phase 3
Withdrawn
Conditions
Acute Myeloid Leukemia
Interventions
Drug: Treatment according to Physician's Choice
Drug: Standard of Care Chemotherapy
First Posted Date
2020-12-19
Last Posted Date
2022-05-25
Lead Sponsor
University Hospital Heidelberg
Registration Number
NCT04676243

Systematic Evaluation of Human Explant Model Systems Engineering

Recruiting
Conditions
Solid Tumor, Adult
First Posted Date
2020-12-17
Last Posted Date
2021-12-21
Lead Sponsor
University Hospital Heidelberg
Target Recruit Count
100
Registration Number
NCT04671654
Locations
🇩🇪

University of Heidelberg / NCT, Heidelberg, Germany

Registry Study of Proton Radiotherapy in Lymphoma

Recruiting
Conditions
Mediastinal Lymphoma
First Posted Date
2020-11-03
Last Posted Date
2024-01-05
Lead Sponsor
University Hospital Heidelberg
Target Recruit Count
200
Registration Number
NCT04613388
Locations
🇩🇪

University Hospital Heidelberg, Heidelberg, Germany

Decision Aid to Support Advanced Cancer Patients

Not Applicable
Recruiting
Conditions
Advanced Cancer
Interventions
Other: Decision Aid
First Posted Date
2020-10-28
Last Posted Date
2023-01-10
Lead Sponsor
University Hospital Heidelberg
Target Recruit Count
70
Registration Number
NCT04606238
Locations
🇩🇪

University Hospital Heidelberg, Heidelberg, Germany

Impact of an Anesthesia Care Handover-Checklist on Adverse Perioperative Outcome

Conditions
Major Surgery
Interventions
Other: AnCHor-Checklist implementation
First Posted Date
2020-10-09
Last Posted Date
2020-11-03
Lead Sponsor
University Hospital Heidelberg
Target Recruit Count
300
Registration Number
NCT04582513
Locations
🇩🇪

Department of Anaesthesiology, University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany

Individualized Blood Pressure Management During Endovascular Stroke Treatment

Not Applicable
Completed
Conditions
Acute Ischemic Stroke
Interventions
Procedure: INDIVIDUALIZED BLOOD PRESSURE MANAGEMENT DURING ENDOVASCULAR TREATMENT OF ACUTE ISCHEMIC STROKE UNDER PROCEDURAL SEDATION
First Posted Date
2020-10-08
Last Posted Date
2022-11-08
Lead Sponsor
University Hospital Heidelberg
Target Recruit Count
250
Registration Number
NCT04578288
Locations
🇩🇪

Department of Neurology, University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany

© Copyright 2025. All Rights Reserved by MedPath